Evidence map›Paper›PMID 39588457›Full record

ArticleCureus2024

An Evaluation of the Most Convenient and Effective Procedure for Reducing the Loading Time of Epirubicin Into the Drug-Eluting Bead M1 (DC Bead M1™).

Yusuke Kawamura, Norio Akuta, Shigeki Yamamoto, Yasuka Eriksson, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yusuke KawamuraHepatology, Toranomon Hospital, Tokyo, JPN.
Norio AkutaHepatology, Toranomon Hospital, Tokyo, JPN.
Shigeki YamamotoHepatology, Toranomon Hospital, Tokyo, JPN.
Yasuka ErikssonHepatology, Toranomon Hospital, Tokyo, JPN.
Tetsuya HosakaHepatology, Toranomon Hospital, Tokyo, JPN.
Satoshi SaitohHepatology, Toranomon Hospital, Tokyo, JPN.
Hitomi SezakiHepatology, Toranomon Hospital, Tokyo, JPN.
Fumitaka SuzukiHepatology, Toranomon Hospital, Tokyo, JPN.
Kenji IkedaHepatology, Toranomon Hospital, Tokyo, JPN.
Hiromitsu KumadaHepatology, Toranomon Hospital, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and objective Drug-eluting beads (DEB) have been highly useful in the current treatment strategies for multiple and large hepatocellular carcinomas (HCC) with or without systemic therapy. Recently, smaller beads have become available in Japan. In this study, we aimed to evaluate the most convenient and effective way to reduce the loading time of epirubicin into the drug-eluting beads M1 (DC Bead M1

Indexed as

advanced hepatocellular carcinomadc bead m1drug-eluting beadepirubicinsystemic therapy

Identifiers

PMID39588457
PMCPMC11586879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.